nafenopin has been researched along with carnitine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amigo, L; Bronfman, M; Cárdenas, L; Hidalgo, PC; Morales, MN; Nuñez, L; Orellana, A | 1 |
| Moody, DE; Reddy, JK | 1 |
2 other study(ies) available for nafenopin and carnitine
| Article | Year |
|---|---|
Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.
Topics: Acyl Coenzyme A; Animals; Biotransformation; Blood Platelets; Carnitine; Cells, Cultured; Clofibric Acid; Fibric Acids; Humans; Kinetics; Lipids; Liver; Nafenopin; Octoxynol; Palmitic Acid; Palmitic Acids; Polyethylene Glycols; Rats; Rats, Inbred Strains | 1992 |
Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Topics: Acetyltransferases; Animals; Biphenyl Compounds; Butyrates; Carnitine; Catalase; Clofibrate; Ethers; Female; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred Strains; Microbodies; Microscopy, Electron; Nafenopin; Organ Size; Organoids; Perfusion; Propionates; Rats; Sex Factors; Stimulation, Chemical | 1974 |